Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/19114694/ below:

Short delay in initiation of radiotherapy may not affect outcome of patients with glioblastoma: a secondary analysis from the radiation therapy oncology group database

Affiliations

• ¹ Departments of Oncology, Tel Aviv Medical Center, Tel Aviv, Israel. deborahblumenthal@gmail.com

• PMID: 19114694
• PMCID: PMC2645087
• DOI: 10.1200/JCO.2008.18.9035

Item in Clipboard

Deborah T Blumenthal et al. J Clin Oncol. 2009.

• ¹ Departments of Oncology, Tel Aviv Medical Center, Tel Aviv, Israel. deborahblumenthal@gmail.com

• PMID: 19114694
• PMCID: PMC2645087
• DOI: 10.1200/JCO.2008.18.9035

Item in Clipboard

Purpose: To analyze the Radiation Therapy Oncology Group (RTOG) database of patients with glioblastoma and appraise whether outcome was influenced by time to initiation of radiation therapy (RT).

Patients and methods: From 1974 through 2003, adult patients with histologically confirmed supratentorial glioblastoma were enrolled onto 16 RTOG studies. Of 3,052 enrolled patients, 197 patients (6%) were either initially rendered ineligible or had insufficient chronologic data, leaving a cohort of 2,855 patients for the present analysis. We selected four patient groups based on the interval from surgery to the start of RT: <or= 2 weeks, 2 to 3 weeks, 3 to 4 weeks, more than 4 weeks to the protocol eligibility limit of 6 weeks. Survival times were estimated by the Kaplan-Meier method. Multivariate analysis incorporated variables of time interval, recursive partitioning analysis (RPA) class, and treatment regimen.

Results: No decrement in survival could be identified with increasing time to initiation of RT. Among our four temporal groupings, median survival time was unexpectedly and significantly greater in the group with the longest interval (> 4 weeks) than in those with the shortest delay (<or= 2 weeks): respectively, 12.5 months versus 9.2 months (P < .0001). On multivariate analysis, with overall survival as the end point, time interval more than 4 weeks and lower RPA class were both significant predictors of improved outcome. Treatment regimen was not a significant factor.

Conclusion: There is no evident reduction in survival by delaying initiation of RT within the relatively narrow constraint of 6 weeks. An unanticipated yet significantly superior outcome was identified for patients for whom RT was delayed beyond 4 weeks from surgery.

PubMed Disclaimer

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

Overall survival by surgery-to-radiation therapy…

Overall survival by surgery-to-radiation therapy time interval groups.

Overall survival by surgery-to-radiation therapy time interval groups.

• Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution.

  Mohan DS, Suh JH, Phan JL, Kupelian PA, Cohen BH, Barnett GH. Mohan DS, et al. Int J Radiat Oncol Biol Phys. 1998 Dec 1;42(5):981-7. doi: 10.1016/s0360-3016(98)00296-x. Int J Radiat Oncol Biol Phys. 1998. PMID: 9869219

• Supratentorial glioblastoma treated with radiotherapy: use of the Radiation Therapy Oncology Group recursive partitioning analysis grouping for predicting survival.

  Fujii O, Soejima T, Kuwatsuka Y, Harada A, Ota Y, Tsujino K, Sasaki M, Kudo H, Nishihara M, Taomoto K. Fujii O, et al. Jpn J Clin Oncol. 2010 Aug;40(8):726-31. doi: 10.1093/jjco/hyq051. Epub 2010 Apr 21. Jpn J Clin Oncol. 2010. PMID: 20410057

• Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-beta for supratentorial glioblastoma: results of RTOG 9710.

  Colman H, Berkey BA, Maor MH, Groves MD, Schultz CJ, Vermeulen S, Nelson DF, Mehta MP, Yung WK; Radiation Therapy Oncology Group. Colman H, et al. Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):818-24. doi: 10.1016/j.ijrobp.2006.05.021. Epub 2006 Aug 2. Int J Radiat Oncol Biol Phys. 2006. PMID: 16887285 Clinical Trial.

• Comparison of survival between cerebellar and supratentorial glioblastoma patients: surveillance, epidemiology, and end results (SEER) analysis.

  Jeswani S, Nuño M, Folkerts V, Mukherjee D, Black KL, Patil CG. Jeswani S, et al. Neurosurgery. 2013 Aug;73(2):240-6; discussion 246; quiz 246. doi: 10.1227/01.neu.0000430288.85680.37. Neurosurgery. 2013. PMID: 23615082

• [Clinical prognostic factors of adult supratentorial glioblastoma].

  Jiang HH, Ren XH, Cui Y, Li MX, Yang KY, Lei YF, Lin S. Jiang HH, et al. Zhonghua Wai Ke Za Zhi. 2019 May 1;57(5):377-382. doi: 10.3760/cma.j.issn.0529-5815.2019.05.011. Zhonghua Wai Ke Za Zhi. 2019. PMID: 31091594 Chinese.

• Prognostic value of the interval from surgery to initiation of radiation therapy in correlation with some histo-clinical parameters in patients with malignant supratentorial gliomas.

  Gliński B, Urbański J, Hetnał M, Małecki K, Jarosz M, Mucha-Małecka A, Chrostowska A, Jakubowicz E, Frączek-Błachut B, Dymek P. Gliński B, et al. Contemp Oncol (Pozn). 2012;16(1):34-7. doi: 10.5114/wo.2012.27334. Epub 2012 Feb 29. Contemp Oncol (Pozn). 2012. PMID: 23788852 Free PMC article.

• The impact of overall radiotherapy treatment time and delay in initiation of radiotherapy on local control and distant metastases in gastric cancer.

  Soyfer V, Geva R, Michelson M, Inbar M, Shacham-Shmueli E, Corn BW. Soyfer V, et al. Radiat Oncol. 2014 Mar 23;9:81. doi: 10.1186/1748-717X-9-81. Radiat Oncol. 2014. PMID: 24655942 Free PMC article.

• Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy.

  Noel G, Huchet A, Feuvret L, Maire JP, Verrelle P, Le Rhun E, Aumont M, Thillays F, Sunyach MP, Henzen C, Missohou F, de Crevoisier R, Bondiau PY, Collin P, Durando X, Truc G, Kerr C, Bernier V, Clavier JB, Atlani D, D'Hombres A, Vinchon-Petit S, Lagrange JL, Taillandier L. Noel G, et al. J Neurooncol. 2012 Aug;109(1):167-75. doi: 10.1007/s11060-012-0883-7. Epub 2012 Jun 2. J Neurooncol. 2012. PMID: 22660920

• A clinical care pathway to improve the acute care of patients with glioma.

  Riblet NBV, Schlosser EM, Snide JA, Ronan L, Thorley K, Davis M, Hong J, Mason LP, Cooney TJ, Jalowiec L, Kennedy NL, Richie S, Nalepinski D, Fadul CE. Riblet NBV, et al. Neurooncol Pract. 2016 Sep;3(3):145-153. doi: 10.1093/nop/npv050. Epub 2015 Oct 23. Neurooncol Pract. 2016. PMID: 31386082 Free PMC article. Review.

• Impact of Time Factors on Outcome in Patients with Head and Neck Cancer Treated with Definitive Radio(Chemo)Therapy.

  Dahlke S, Steinmann D, Christiansen H, Durisin M, Eckardt A, Wegener G, Bremer M, Meyer A. Dahlke S, et al. In Vivo. 2017 Sep-Oct;31(5):949-955. doi: 10.21873/invivo.11152. In Vivo. 2017. PMID: 28882964 Free PMC article.

1. 1. Walker MD, Green SB, Byar DP, et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant gliomas after surgery. N Engl J Med. 1980;303:1323–1329. - PubMed
2. 1. Keime-Guibert F, Chinot O, Taillandier L, et al. Radiotherapy for glioblastoma in elderly. N Engl J Med. 2007;356:1527–1535. - PubMed
3. 1. Nelson D, Schoenfeld D, Weinstein A, et al. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: Preliminary results of an RTOG study. Int J Radiat Oncol Biol Phys. 1983;9:1143–11151. - PubMed
4. 1. Souhami L, Seiferheldl W, Brachman D, et al. Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: Report of RTOG 93-05. Int J Radiat Oncol Biol Phys. 2004;60:853–860. - PubMed
5. 1. Werner-Wasik M, Scott C, Nelson D, et al. Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiotherapy with carmustine for adults with supratentorial malignant gliomas. Cancer. 1996;77:1535–1543. - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3